RAPT Therapeutics, Inc.
RAPT
$31.90
-$0.43-1.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -105.64M | -106.49M | -116.51M | -129.87M | -107.49M |
| Total Depreciation and Amortization | 972.00K | 1.06M | 1.14M | 1.20M | 1.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.24M | 18.06M | 19.00M | 19.46M | 18.60M |
| Change in Net Operating Assets | -150.00K | -4.38M | -12.26M | 25.91M | -12.97M |
| Cash from Operations | -86.58M | -91.74M | -108.63M | -83.30M | -100.61M |
| Capital Expenditure | -84.00K | -101.00K | -60.00K | -122.00K | -188.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.62M | -46.62M | -20.19M | 52.82M | 74.37M |
| Cash from Investing | -56.70M | -46.72M | -20.25M | 52.70M | 74.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 143.31M | 143.28M | 143.82M | 152.85M | 10.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 143.31M | 143.28M | 143.82M | 152.85M | 10.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.00K | 4.81M | 14.94M | 122.26M | -16.24M |